SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-058848
Filing Date
2023-07-21
Accepted
2023-07-21 16:15:18
Documents
3
Period of Report
2023-07-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea182152-6k_tiziana.htm 6-K 14549
2 NEWS SERVICE ANNOUNCEMENT, DATED JULY 21, 2023 ea182152ex99-1_tiziana.htm EX-99.1 7964
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4640
  Complete submission text file 0001213900-23-058848.txt   30179
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 231102677
SIC: 2834 Pharmaceutical Preparations